Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

[Albumin infusion for paracentesis in patients with cirrhosis: dogma or evidence?].

Manzocchi S, Nendaz M, Spahr L.

Rev Med Suisse. 2012 Oct 17;8(358):1956, 1958-60. French.

PMID:
23198648
2.

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, Morgando A, Marzano A, Rizzetto M.

Dig Liver Dis. 2011 Nov;43(11):881-6. doi: 10.1016/j.dld.2011.06.001.

PMID:
21741331
3.

Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.

Appenrodt B, Wolf A, Grünhage F, Trebicka J, Schepke M, Rabe C, Lammert F, Sauerbruch T, Heller J.

Liver Int. 2008 Aug;28(7):1019-25. doi: 10.1111/j.1478-3231.2008.01734.x.

PMID:
18410283
4.

Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.

Singh V, Kumar R, Nain CK, Singh B, Sharma AK.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):303-7.

PMID:
16460491
5.

Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.

Hamdy H, ElBaz AA, Hassan A, Hassanin O.

J Clin Gastroenterol. 2014 Feb;48(2):184-8. doi: 10.1097/MCG.0b013e31829ae376.

PMID:
23842215
6.

Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.

Bernardi M, Caraceni P, Navickis RJ, Wilkes MM.

Hepatology. 2012 Apr;55(4):1172-81. doi: 10.1002/hep.24786.

PMID:
22095893
7.

Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.

Sola-Vera J, Miñana J, Ricart E, Planella M, González B, Torras X, Rodríguez J, Such J, Pascual S, Soriano G, Pérez-Mateo M, Guarner C.

Hepatology. 2003 May;37(5):1147-53.

PMID:
12717396
8.

Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.

Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.

Am J Gastroenterol. 1997 Mar;92(3):394-9.

PMID:
9068457
9.

Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.

Arroyo V, Ginès P, Planas R.

Gastroenterol Clin North Am. 1992 Mar;21(1):237-56. Review.

PMID:
1568775
10.

Is albumin infusion necessary after large volume paracentesis?

Cárdenas A, Ginès P, Runyon BA.

Liver Int. 2009 May;29(5):636-40; discussion 640-1. doi: 10.1111/j.1478-3231.2009.02027_1.x. No abstract available.

PMID:
19413666
11.

Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.

García-Compean D, Blanc P, Larrey D, Daures JP, Hirtz J, Mendoza E, Maldonado H, Michel H.

Ann Hepatol. 2002 Jan-Mar;1(1):29-35.

PMID:
15114293
12.
13.

Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.

Singh V, Kumar B, Nain CK, Singh B, Sharma N, Bhalla A, Sharma AK.

J Intern Med. 2006 Jul;260(1):62-8.

14.

Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.

Sersté T, Francoz C, Durand F, Rautou PE, Melot C, Valla D, Moreau R, Lebrec D.

J Hepatol. 2011 Oct;55(4):794-9. doi: 10.1016/j.jhep.2011.01.034.

PMID:
21354230
15.

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, Torres M, Humbert P, Rimola A, Llach J, et al.

Gastroenterology. 1988 Jun;94(6):1493-502.

PMID:
3360270
16.

Management of refractory ascites.

Singhal S, Baikati KK, Jabbour II, Anand S.

Am J Ther. 2012 Mar;19(2):121-32. doi: 10.1097/MJT.0b013e3181ff7a8b. Review.

PMID:
21192246
17.
18.

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.

Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Solà R, Ginès P, Terg R, Inglada L, Vaqué P, Salerno F, Vargas V, Clemente G, Quer JC, Jiménez W, Arroyo V, Rodés J.

Gastroenterology. 1996 Oct;111(4):1002-10.

PMID:
8831595
19.

Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.

Moreau R, Asselah T, Condat B, de Kerguenec C, Pessione F, Bernard B, Poynard T, Binn M, Grangé JD, Valla D, Lebrec D.

Gut. 2002 Jan;50(1):90-4.

20.

Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.

Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, Nicolini A, Salvatori F.

Hepatology. 2004 Sep;40(3):629-35.

PMID:
15349901
Items per page

Supplemental Content

Support Center